INTRODUCTION AND OBJECTIVES: Following anterior urethroplasty (AU) for male urethral stricture disease (USD) surgical pathology is seldom obtained or focuses on excluding malignancy. This potentially represents a missed opportunity to better understand USD pathophysiology, which is poorly understood. The purpose of the current study is to re-review stricture specimens for histologic elements specific to lichen sclerosus and then to determine if pathology affects presentation or surgical outcomes.
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METHODS: All available pathologic specimens from men undergoing AU for USD from 2010-2017 at a single institution were re-reviewed by a blinded pathologist directed to "rule out lichen sclerosus" (hyperkeratosis, thickened dermis, basal layer degeneration, lymphocytic infiltrate, subepithelial fibrosis). Cohorts were then created comprised of inflammatory and non-inflammatory strictures. PROM and outcomes data were compared.
RESULTS: Pathology from 100 AU cases was rereviewed. Chronic inflammation was present in 44% of cases and 21% had ! 2 histologic features of LS (versus 6% on primary review). Patients with inflammatory strictures were more likely to be diabetic and report worse overall health but other PROM data was similar (Table) . Stricture lengths were similar between cohorts, though the proximal bulb was largely spared from inflammatory strictures. Overall surgical failure rate (9%) was not statistically different between groups at median follow up of 12.1 months.
CONCLUSIONS: Chronic inflammation is prevalent in a significant percentage of USD specimens, indicating a continued presentation of antigen(s) in the region yet to be defined. Associations with diabetes and sparing of specific urethral segments may help inform the search for a pathophysiology. Recently, the clinical use of prostate multiparametric magnetic resonance imaging (mpMRI) has been increasingly adopted for the diagnosis of prostate cancer (PCa). However, false positives and false negatives occur not uncommonly. The potential cellular mechanisms responsible for this discrepancy have not been experimentally explored. We examined the influence of one potential cellular mechanismeimmune cell infiltrationeon prostate mpMRI appearance.
Source of Funding: None
METHODS: With Institutional Review Board approval, we identified patients who had prostate mpMRI and subsequently underwent a MRI/US software fusion biopsy. Biopsies were performed with the UroNav platform (Invivo Corporation, Gainesville, FL). We included patients with PI-RADS classification 4 or 5 lesions. We excluded patients with a clinical history of prostatitis, prior biopsy within six months of mpMRI, multiple lesions, and small lesions (<0.25 mL) that may result in technical miss at the time of biopsy. We obtained two cores from each patient e from the MRI targeted biopsy (MRIþ) and from a systematic biopsy that was geometrically distant from the mpMRI lesion (MRI-). Biopsy specimens were stained for a pan-leukocyte marker (CD45) as well as a B cell marker (CD20). Leukocyte density (LD) was measured by a pathologist blinded to the mpMRI as number of cells per mm of biopsy core. RESULTS: We included 23 patients for this study. We found that the mean LD was significantly higher in MRIþ cores than for MRIcores (71.9AE25.4 versus 42.1AE10.6 cells/mm, p[0.039). We also found that there was no difference between mean LD for MRIþ cores with PCa and MRIþ cores with no cancer (71.8AE55.2 versus 72.0AE77.5 cells/mm, p[0.99). These findings are summarized in Figure 1 . Finally, for the subset of patients with MRIþ cores with PCa and MRI-cores without cancer (n[10), we found that CD20þ B cells were disproportionally represented in the MRIþ cores (13.7 versus 2.9% of the total leukocytes, p[0.138).
CONCLUSIONS: The immune cell composition within the prostate (whether it is benign or associated with PCa) contributes to prostate mpMRI appearance. In patients where prostate mpMRI detects PCa successfully, B cells are disproportionately represented, suggesting their role in the tumor microenvironment of PCa that can be seen on mpMRI.
